Search
for
Sort by
Research 181–210 of 214
- Immune therapies for alopecia areata: evidence and new perspectives
- Cosmeceutical and Dermatological Potential of Olive Mill Wastewater: A Sustainable and Eco-Friendly Source of Natural Ingredients
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Alopecia areata: current concepts
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Microneedles: Selected Applications for Pediatrics
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Analyse trichoskopischer Bilder mit tiefen neuronalen Netzen zur Diagnose und Aktivitätsbewertung von Alopecia areata – eine retrospektive Studie
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials